| Unique ID issued by UMIN | UMIN000056277 |
|---|---|
| Receipt number | R000064250 |
| Scientific Title | An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial- |
| Date of disclosure of the study information | 2024/11/30 |
| Last modified on | 2024/11/26 15:50:34 |
An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial-
An evaluation trial of exercise performance following the intake of test food
An evaluation trial of exercise performance following the intake of test food in corporate track and field athletes -Open trial-
An evaluation trial of exercise performance following the intake of test food
| Japan |
Healthy Volunteers
| Adult |
Others
NO
To investigate the effects on exercise performance after low-altitude and high-altitude training, and high-altitude adaptation following the continuous intake of test food.
Efficacy
ventilatory threshold related indicators
oxygen uptake, oxygen utilization efficiency, ventilation volume, carbon dioxide output, respiratory exchange ratio, respiratory rate, heart rate, exercise duration, subjective exercise intensity, urinary excretion volume of test food components
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
| Food |
exercise load, test food
| 20 | years-old | <= |
| Not applicable |
Female
1) Individuals who consented to participate in this trial through a written agreement.
2) Healthy female.
3) Individuals who able to maintain a diet, drink, intake of test food, urination, and maintaining rest according to the schedule instructed by the test person in charge.
1) Individuals whose blood test results are judged to be ineligible for this trial by lead principal investigator.
2) Individuals with gastrointestinal, cardiovascular, endocrine, or other disorders, or with a history of such disorders, who are judged by lead principal investigator to be ineligible for the trial.
3) As a rule, individuals who regularly use drugs for the treatment of diseases.
4) Individuals who are taking healthy foods that may affect this trial.
5) Individuals with allergies.
6) Individuals judged to be ineligible for this trial due to other reasons by lead principal investigator.
8
| 1st name | Yasutaka |
| Middle name | |
| Last name | Ikeda |
Otsuka Pharmaceutical Co., Ltd.
Otsu Nutraceuticals Research Institute
520-0106
1-11-1 Karasaki, Otsu, Shiga
+81-77-519-0111
Ikeda.Yasutaka@otsuka.jp
| 1st name | Yasutaka |
| Middle name | |
| Last name | Ikeda |
Otsuka Pharmaceutical Co., Ltd.
Otsu Nutraceuticals Research Institute
520-0106
1-11-1 Karasaki, Otsu, Shiga
+81-77-519-0111
Ikeda.Yasutaka@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
None
Self funding
None
The Ethics Committee of Otsuka Pharmaceutical Co., Ltd.
Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo 108-8242, Japan
+81-3-6717-1499
shimizu_se@otsuka.jp
NO
| 2024 | Year | 11 | Month | 30 | Day |
Scheduled to be documented after publication.
Unpublished
Scheduled to be documented after publication.
8
Scheduled to be documented after publication.
| 2024 | Year | 11 | Month | 26 | Day |
Scheduled to be documented after publication.
Scheduled to be documented after publication.
Scheduled to be documented after publication.
Scheduled to be documented after publication.
Completed
| 2019 | Year | 06 | Month | 17 | Day |
| 2019 | Year | 06 | Month | 26 | Day |
| 2019 | Year | 06 | Month | 26 | Day |
| 2019 | Year | 11 | Month | 27 | Day |
| 2020 | Year | 04 | Month | 08 | Day |
| 2024 | Year | 11 | Month | 26 | Day |
| 2024 | Year | 11 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064250